Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia

被引：1

作者：

Alqahtani, Shaikha ^{[1
]}

Ramakrishnan, Ramya ^{[1
]}

E, Shuyu ^{[2
]}

Wang, Sa A. ^{[2
]}

Nunez, Cesar ^{[1
]}

McCall, David ^{[1
]}

Garcia, Miriam B. ^{[1
]}

Roth, Michael E. ^{[1
]}

Cuglievan, Branko ^{[1
]}

Gibson, Amber ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Pediat, 1515 Holcombe Blvd, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Div Pathol, Houston, TX 77030 USA

来源：

PEDIATRIC BLOOD & CANCER | 2024年 / 71卷 / 08期

关键词：

D O I：

10.1002/pbc.31123

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 13 条

[1] The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia [J].

Aumann, Shlomzion ;

Shaulov, Adir ;

Haran, Arnon ;

Even-Zohar, Noa Gross ;

Vainstein, Vladimir ;

Nachmias, Boaz .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)

[2] The incidence and type of cancer in patients with ataxia-telangiectasia via a retrospective single-centre study [J].

Bakhtiar, Shahrzad ;

Salzmann-Manrique, Emilia ;

Donath, Helena ;

Woelke, Sandra ;

Duecker, Ruth P. ;

Fritzemeyer, Stefanie ;

Schubert, Ralf ;

Huenecke, Sabine ;

Kieslich, Matthias ;

Klingebiel, Thomas ;

Bader, Peter ;

Zielen, Stefan .

BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (05) :879-887

[3] Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia [J].

Dunsmore, Kimberly P. ;

Winter, Stuart S. ;

Devidas, Meenakshi ;

Wood, Brent L. ;

Esiashvili, Natia ;

Chen, Zhiguo ;

Eisenberg, Nancy ;

Briegel, Nikki ;

Hayashi, Robert J. ;

Gastier-Foster, Julie M. ;

Carroll, Andrew J. ;

Heerema, Nyla A. ;

Asselin, Barbara L. ;

Rabin, Karen R. ;

Zweidler-Mckay, Patrick A. ;

Raetz, Elizabeth A. ;

Loh, Mignon L. ;

Schultz, Kirk R. ;

Winick, Naomi J. ;

Carroll, William L. ;

Hunger, Stephen P. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (28) :3282-3293

[4] Cancer in Children With Fanconi Anemia and Ataxia-Telangiectnsia-A Nationwide Register-Based Cohort Study in Germany [J].

Dutzmann, Christina M. ;

Spix, Claudia ;

Popp, Isabell ;

Kaiser, Melanie ;

Erdmann, Friederike ;

Erlacher, Miriam ;

Doerk, Thilo ;

Schindler, Detlev ;

Kalb, Reinhard ;

Kratz, Christian P. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (01) :32-+

[5]

Farhadfar Nosha, 2021, Hematol Oncol Stem Cell Ther, V14, P246, DOI 10.1016/j.hemonc.2019.10.002

[6] Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma [J].

Gibson, Amber ;

Trabal, Adriana ;

McCall, David ;

Khazal, Sajad ;

Toepfer, Laurie ;

Bell, Donna H. ;

Roth, Michael ;

Mahadeo, Kris M. ;

Nunez, Cesar ;

Short, Nicholas J. ;

DiNardo, Courtney ;

Konopleva, Marina ;

Issa, Ghayas C. ;

Ravandi, Farhad ;

Jain, Nitin ;

Borthakur, Gautam ;

Kantarjian, Hagop M. ;

Jabbour, Elias ;

Cuglievan, Branko .

CANCERS, 2022, 14 (01)

[7] Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study [J].

Karol, Seth E. ;

Alexander, Thomas B. ;

Budhraja, Amit ;

Pounds, Stanley B. ;

Canavera, Kristin ;

Wang, Lei ;

Wolf, Joshua ;

Klco, Jeffery M. ;

Mead, Paul E. ;

Das Gupta, Soumyasri ;

Kim, Su Y. ;

Salem, Ahmed Hamed ;

Palenski, Tammy ;

Lacayo, Norman J. ;

Pui, Ching-Hon ;

Opferman, Joseph T. ;

Rubnitz, Jeffrey E. .

LANCET ONCOLOGY, 2020, 21 (04) :551-560

[8] Venetoclax and dexamethasone synergize with inotuzumab ozogamicin-induced DNA damage signaling in B-lineage ALL [J].

Kirchhoff, Hanna ;

Karsli, Uemran ;

Schoenherr, Caroline ;

Battmer, Karin ;

Erschow, Sergej ;

Talbot, Steven R. ;

Steinemann, Doris ;

Heuser, Michael ;

Heidenreich, Olaf ;

Hilfiker-Kleiner, Denise ;

Ganser, Arnold ;

Eder, Matthias ;

Scherr, Michaela .

BLOOD, 2021, 137 (19) :2657-2661

[9] Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders [J].

Pastorczak, Agata ;

Attarbaschi, Andishe ;

Bomken, Simon ;

Borkhardt, Arndt ;

van der Werff ten Bosch, Jutte ;

Elitzur, Sarah ;

Gennery, Andrew R. ;

Hlavackova, Eva ;

Kerekes, Arpad ;

Krenova, Zdenka ;

Mlynarski, Wojciech ;

Szczepanski, Tomasz ;

Wassenberg, Tessa ;

Loeffen, Jan .

CANCERS, 2022, 14 (08)

[10] Venetoclax and navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma [J].

Pullarkat, Vinod A. ;

Lacayo, Norman J. ;

Jabbour, Elias ;

Rubnitz, Jeffrey E. ;

Bajel, Ashish ;

Laetsch, Theodore W. ;

Leonard, Jessica ;

Colace, Susan, I ;

Khaw, Seong Lin ;

Fleming, Shaun A. ;

Mattison, Ryan J. ;

Norris, Robin ;

Opferman, Joseph T. ;

Roberts, Kathryn G. ;

Zhao, Yaqi ;

Qu, Chunxu ;

Badawi, Mohamed ;

Schmidt, Michelle ;

Tong, Bo ;

Pesko, John C. ;

Sun, Yan ;

Ross, Jeremy A. ;

Vishwamitra, Deeksha ;

Rosenwinkel, Lindsey ;

Kim, Su Young ;

Jacobson, Amanda ;

Mullighan, Charles G. ;

Alexander, Thomas B. ;

Stock, Wendy .

CANCER DISCOVERY, 2021, 11 (06) :1440-1453

← 1 2 →